help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 24, 2003, doi:10.1165/rcmb.2002-0157OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0157OCv1
29/4/465    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Z.
Right arrow Articles by Rhoades, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.
Right arrow Articles by Rhoades, R. A.
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 465-471, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2002-0157OC

Hypoxia Inhibits Myosin Phosphatase in Pulmonary Arterial Smooth Muscle Cells

Role of Rho-Kinase

Zhiqian Wang, M. Carita Lannér, Najia Jin, Darl Swartz, Liang Li and Rodney A. Rhoades

Department of Cellular/Integrative Physiology, and Department of Anatomy/Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana

Address correspondence to: Dr. M. Carita Lannér, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202. E-mail: clanner{at}iupui.edu

Rho-kinase was recently found to phosphorylate the myosin-binding subunit (MBS) of myosin phosphatase (MP) and to regulate MP activity. Although myosin light chain (MLC) phosphorylation in pulmonary arterial smooth muscle cells (PASMCs) is thought to be the cellular/molecular basis for hypoxic pulmonary vasoconstriction (HPV), very little is known about the role that Rho-kinase/MP plays in HPV. Rat PASMCs were cultured and made hypoxic (PO2 = 23 ± 2 mm Hg). Cells exposed to normoxia (PO2 ~ 148 mm Hg) served as controls. PASMCs exposed to hypoxia showed a significant increase in MLC and MBS phosphorylation, and a significant decrease in MP activity. Rho-kinase inhibitors (HA1077 or Y-27632) blocked hypoxia-induced MP inactivation and inhibited the hypoxia-induced MLC phosphorylation. Hypoxia was also found to induce stress fiber formation and actin polymerization in cultured PASMCs. In summary, these data show that MP inhibition in PASMCs is linked to activation of Rho-kinase, and that hypoxia inhibits the MP signaling pathway via Rho-kinase.

Abbreviations: Dulbecco's modified Eagle's medium, DMEM • dithiothreitol, DTT • fetal bovine serum, FBS • fluorescein isothiocyanate, FITC • hypoxic pulmonary vasoconstriction, HPV • immunoglobulin, IgG • lysophosphatidic acid, LPA • myosin-binding subunit, MBS • myosin light chain, MLC • MLC kinase, MLCK • myosin phosphatase, MP • okadaic acid, OA • pulmonary artery smooth muscle cell, PASMC • phosphate-buffered saline, PBS • Rho-associated serine/threonine kinase, Rho-kinase • sodium dodecyl sulfate, SDS • trichloroacetic acid, TCA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society.
  ATS Best of the Web